Stay updated with breaking news from French Early Access Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Zevra Therapeutics, Inc. (NASDAQ:ZVRA) Q2 2023 Earnings Call Transcript August 17, 2023 Operator: Good morning, and welcome to the Zevra Therapeutics Second Quarter 2023 Corporate and Financial Results Conference Call. [Operator Instructions] Please be advised that today’s call is being recorded. I will now turn the call over to Nichol Ochsner, Zevra Therapeutics Vice President, […]
Data from multiple studies of investigational bispecific drug zanidatamab, including pivotal Phase 2 biliary tract cancers (BTC) trial results, demonstrate...
Data from multiple studies of investigational bispecific drug zanidatamab, including pivotal Phase 2 biliary tract cancers (BTC) trial results, demonstrate breakthrough HER2-targeted pan-tumor
PTC Therapeutics (NASDAQ:NASDAQ:PTCT) Q2 2022 Earnings Conference Call August 4, 2022 16:30 ET Company Participants Kylie O'Keefe - Senior Vice President, Head of Global Commercial &...